Federica Novarella
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Real-world analytical and clinical evaluation of the Siemens Atellica® immunoassay for plasma neurofilament light chain in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: April 19, 2026
Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis.
Journal: Journal of the neurological sciences
Published: October 01, 2025
Novel missense ALDH18A1 variant in a family with autosomal dominant spastic paraplegia.
Journal: Journal of neurology
Published: August 02, 2025
Plasma Neurofilament Light Chain Is Associated with Cognitive Functions but Not Patient-Reported Outcomes in Multiple Sclerosis.
Journal: Neurology international
Published: July 01, 2025
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis.
Journal: Journal of the neurological sciences
Published: March 03, 2025
Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis.
Journal: Journal of neurology
Published: February 05, 2025
Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysis.
Journal: European journal of neurology
Published: June 12, 2024
Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosis.
Journal: Journal of the neurological sciences
Published: April 04, 2024
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis.
Journal: Journal of neurology
Published: February 15, 2024
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: May 29, 2023
Last Updated: 09/26/2026